A provider-focused update on Brenzavvy availability, distribution, insurance coverage, and what to tell patients who can't fill their prescription in 2026.
If your patients are reporting difficulty filling Brenzavvy (Bexagliflozin) prescriptions, this guide provides the clinical and logistical context you need. Brenzavvy occupies a unique position in the SGLT2 inhibitor class — it's therapeutically comparable to its competitors but follows a fundamentally different distribution model that affects how and where patients can access it.
This briefing covers the current availability landscape, prescribing implications, cost considerations, and practical tools to help your patients get their medication.
Bexagliflozin is a selective SGLT2 inhibitor with a mechanism of action consistent with the class. Key prescribing details:
Brenzavvy does not carry a boxed warning, but the class-level risks apply. For patients on insulin or sulfonylureas, consider dose reduction to mitigate hypoglycemia risk.
For full prescribing details, see our clinical overview: What is Brenzavvy: uses, dosage, what you need to know.
Unlike Jardiance (Empagliflozin) and Farxiga (Dapagliflozin), Brenzavvy does not have FDA-approved indications for:
This limits its use in patients where cardiovascular or renal outcomes data influence prescribing decisions. For patients whose primary need is glycemic control and cost is a barrier, Brenzavvy remains a clinically appropriate option.
Brenzavvy is not in shortage per the FDA as of early 2026. However, practical availability is constrained by:
For providers trying to determine where patients can fill prescriptions, Medfinder for Providers offers real-time pharmacy inventory search.
Brenzavvy has limited formulary presence. When covered, it is typically classified as non-preferred brand, requiring prior authorization and/or step therapy. For many patients, the cash price through partner pharmacies is lower than their insurance copay would be for preferred SGLT2 inhibitors.
This creates an unusual dynamic: patients may be better off paying cash for Brenzavvy than using their insurance for Jardiance or Farxiga — particularly those with high-deductible plans or significant coinsurance requirements.
Medfinder's provider portal allows you to search pharmacy availability for Brenzavvy and other medications in real time. You can direct patients to pharmacies with confirmed stock or help them identify the lowest-cost option in their area.
If your patients are ordering through Cost Plus Drugs or Marley Drug, you can send prescriptions electronically to these pharmacies. This streamlines the process and reduces the chance of prescription transfer issues.
Consider sharing these resources with patients asking about Brenzavvy:
When Brenzavvy is not appropriate or accessible, the following alternatives may be considered:
For a detailed comparison, see alternatives to Brenzavvy.
Brenzavvy represents an interesting case study in pharmaceutical access: a clinically effective medication priced affordably by design, but constrained by the very systems (formularies, PBMs, pharmacy stocking practices) that its pricing model bypasses.
As awareness grows among both providers and patients, and as TheracosBio continues to expand distribution partnerships, accessibility is expected to improve. In the meantime, directing patients to online pharmacy options and Medfinder can help close the access gap.
Brenzavvy is a viable SGLT2 inhibitor option for patients whose primary need is affordable glycemic control. Its unique distribution model requires a different approach to prescribing and patient counseling — but the cost savings can be transformative for patients who are paying out of pocket or struggling with high copays on other diabetes medications.
For provider-specific tools and resources, visit medfinder.com/providers.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.
%2C%20Color%3DOriginal.png)
